Columbus Circle Investors’s Bristol-Myers Squibb BMY Stock Holding History

Columbus Circle Investors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,219,600	Closed	-$120M	–	263
2016 Q3	$120M	Sell	2,219,600 -1,168,930	-34%	-$75.1M	1.29%	20
2016 Q2	$249M	Sell	3,388,530 -448,576	-12%	-$31.7M	2.5%	3
2016 Q1	$245M	Buy	3,837,106 +49,244	+1%	+$3.11M	2.18%	8
2015 Q4	$261M	Sell	3,787,862 -158,275	-4%	-$10.5M	2.09%	9
2015 Q3	$234M	Buy	3,946,137 +336,398	+9%	+$21.3M	1.91%	10
2015 Q2	$240M	Buy	3,609,739 +162,342	+5%	+$10.7M	1.7%	10
2015 Q1	$222M	Buy	3,447,397 +176,969	+5%	+$11.1M	1.51%	15
2014 Q4	$193M	Buy	3,270,428 +433,722	+15%	+$24.5M	1.37%	20
2014 Q3	$145M	Sell	2,836,706 -49,830	-2%	-$2.49M	1.04%	31
2014 Q2	$140M	Sell	2,886,536 -148,516	-5%	-$7.32M	0.96%	29
2014 Q1	$158M	Buy	3,035,052 +1,064,878	+54%	+$56.7M	1.05%	31
2013 Q4	$105M	Buy	+1,970,174	New	+$100M	0.72%	48

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Columbus Circle Investors's BMY Position: Q4 2016 in Review

Columbus Circle Investors sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 2,219,600 shares — an estimated $120M sold.

Columbus Circle Investors first reported a position in BMY in Q4 2013 and held it in 12 quarters. The position peaked at $261M in Q4 2015. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Columbus Circle Investors reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Columbus Circle Investors sold 2,219,600 Bristol-Myers Squibb shares in Q4 2016, an estimated $120M.
Columbus Circle Investors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 12 quarters.
Columbus Circle Investors's Bristol-Myers Squibb position peaked at $261M in Q4 2015.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Columbus Circle Investors's 13F filing for Q4 2016, filed 2 Feb 2017.